{"entity":{"type":"insider","cik":"0001409601","url":"/insider/0001409601","json_url":"/insider/0001409601.json","name":"Clancy Paul J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":74,"n_filings":17,"first":"2008-02-14","last":"2026-05-21","span_basis":"filed_date"},"name_variants":[{"name":"Clancy Paul J","source":"filing","n_filings":17,"first_seen":"2008-02-14","last_seen":"2026-05-21"}],"transactions":[{"id":5739654,"accession":"0001409601-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001409601-26-000006","line_url":"/filing/0001409601-26-000006#line-2","is_derivative":false,"issuer_cik":"0000879169","issuer_name":"INCYTE CORP","issuer_ticker":"INCY","issuer_name_source":null,"issuer_url":"/issuer/0000879169","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":94.93,"price_display":"94.93","price_state":"stated","total_value":1423950.0,"total_display":"1,423,950.00","total_whole":"1,423,950","shares_owned_after":23741.0,"shares_owned_after_display":"23,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-21","scope":"insider"},{"id":6619514,"accession":"0000899866-18-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-18-000114","line_url":"/filing/0000899866-18-000114#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS, INC.","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5241.0,"shares_display":"5,241","price_per_share":131.11,"price_display":"131.11","price_state":"stated","total_value":687147.51,"total_display":"687,147.51","total_whole":"687,148","shares_owned_after":93309.0,"shares_owned_after_display":"93,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-10","filed_date":"2018-07-12","scope":"insider"},{"id":6063232,"accession":"0000899866-18-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-18-000040","line_url":"/filing/0000899866-18-000040#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6079.0,"shares_display":"6,079","price_per_share":116.31,"price_display":"116.31","price_state":"stated","total_value":707048.49,"total_display":"707,048.49","total_whole":"707,048","shares_owned_after":89014.0,"shares_owned_after_display":"89,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-08","scope":"insider"},{"id":4113492,"accession":"0001127602-17-015712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-015712","line_url":"/filing/0001127602-17-015712#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9892.0,"shares_display":"9,892","price_per_share":290.0,"price_display":"290.00","price_state":"stated","total_value":2868680.0,"total_display":"2,868,680.00","total_whole":"2,868,680","shares_owned_after":10813.0,"shares_owned_after_display":"10,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-25","filed_date":"2017-04-27","scope":"insider"},{"id":4113322,"accession":"0001127602-17-011701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-011701","line_url":"/filing/0001127602-17-011701#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9891.0,"shares_display":"9,891","price_per_share":291.55,"price_display":"291.55","price_state":"stated","total_value":2883721.05,"total_display":"2,883,721.05","total_whole":"2,883,721","shares_owned_after":20705.0,"shares_owned_after_display":"20,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-13","filed_date":"2017-03-14","scope":"insider"},{"id":4525278,"accession":"0001127602-13-027535","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-027535","line_url":"/filing/0001127602-13-027535#line-2","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26785.0,"shares_display":"26,785","price_per_share":245.0,"price_display":"245.00","price_state":"stated","total_value":6562325.0,"total_display":"6,562,325.00","total_whole":"6,562,325","shares_owned_after":7087.0,"shares_owned_after_display":"7,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-18","filed_date":"2013-09-19","scope":"insider"},{"id":5411813,"accession":"0001127602-13-027474","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001127602-13-027474","line_url":"/filing/0001127602-13-027474","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99030.0,"shares_display":"99,030","price_per_share":238.27437149348683,"price_display":"238.27","price_state":"stated","total_value":23596311.009,"total_display":"23,596,311.01","total_whole":"23,596,311","shares_owned_after":27319.0,"shares_owned_after_display":"27,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-16","filed_date":"2013-09-18","scope":"insider","n_lines":20},{"id":5223556,"accession":"0001127602-13-014981","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-13-014981","line_url":"/filing/0001127602-13-014981","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14489.0,"shares_display":"14,489","price_per_share":224.65950364414383,"price_display":"224.66","price_state":"stated","total_value":3255091.5483,"total_display":"3,255,091.55","total_whole":"3,255,092","shares_owned_after":7987.0,"shares_owned_after_display":"7,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-01","scope":"insider","n_lines":4},{"id":5223538,"accession":"0001127602-13-014981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-13-014981","line_url":"/filing/0001127602-13-014981#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9123.0,"shares_display":"9,123","price_per_share":219.71,"price_display":"219.71","price_state":"stated","total_value":2004414.33,"total_display":"2,004,414.33","total_whole":"2,004,414","shares_owned_after":21576.0,"shares_owned_after_display":"21,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-29","filed_date":"2013-05-01","scope":"insider"},{"id":3279865,"accession":"0001127602-12-003921","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-12-003921","line_url":"/filing/0001127602-12-003921","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21400.0,"shares_display":"21,400","price_per_share":120.0,"price_display":"120.00","price_state":"stated","total_value":2568000.0,"total_display":"2,568,000.00","total_whole":"2,568,000","shares_owned_after":29568.0,"shares_owned_after_display":"29,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-01","filed_date":"2012-02-03","scope":"insider","n_lines":2},{"id":3056671,"accession":"0001127602-12-000448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-000448","line_url":"/filing/0001127602-12-000448","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20244.0,"shares_display":"20,244","price_per_share":112.34939854771784,"price_display":"112.35","price_state":"stated","total_value":2274401.2242,"total_display":"2,274,401.22","total_whole":"2,274,401","shares_owned_after":26742.0,"shares_owned_after_display":"26,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-04","scope":"insider","n_lines":2},{"id":8982752,"accession":"0001127602-11-014105","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001127602-11-014105","line_url":"/filing/0001127602-11-014105","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19716.0,"shares_display":"19,716","price_per_share":98.90889294481639,"price_display":"98.91","price_state":"stated","total_value":1950087.7333,"total_display":"1,950,087.73","total_whole":"1,950,088","shares_owned_after":48497.0,"shares_owned_after_display":"48,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-28","filed_date":"2011-04-29","scope":"insider","n_lines":11},{"id":3929692,"accession":"0001127602-08-007189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-08-007189","line_url":"/filing/0001127602-08-007189#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1553.0,"shares_display":"1,553","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":77650.0,"total_display":"77,650.00","total_whole":"77,650","shares_owned_after":40002.0,"shares_owned_after_display":"40,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-19","filed_date":"2008-09-23","scope":"insider"},{"id":3941711,"accession":"0001209191-08-046441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-046441","line_url":"/filing/0001209191-08-046441","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (Executive VP and CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":568.0,"shares_display":"568","price_per_share":50.663521126760564,"price_display":"50.66","price_state":"stated","total_value":28776.88,"total_display":"28,776.88","total_whole":"28,777","shares_owned_after":42869.0,"shares_owned_after_display":"42,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-08","filed_date":"2008-08-11","scope":"insider","n_lines":2},{"id":2481632,"accession":"0001209191-08-040121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-040121","line_url":"/filing/0001209191-08-040121#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001409601","owner_name":"Clancy Paul J","owner_display_name":"Clancy Paul J","owner_url":"/insider/0001409601","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4208.0,"shares_display":"4,208","price_per_share":56.0074,"price_display":"56.01","price_state":"stated","total_value":235679.1392,"total_display":"235,679.14","total_whole":"235,679","shares_owned_after":37502.0,"shares_owned_after_display":"37,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-01","filed_date":"2008-07-02","scope":"insider"}],"collapsed":true,"next_cursor":"2008-07-01|2481632","ledger_fault":false,"count":{"value":74,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":74,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":74},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000879169","name":"INCYTE CORP","url":"/issuer/0000879169","role":"Director","n_filings":1,"first_seen":"2026-05-21","last_seen":"2026-05-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS, INC.","url":"/issuer/0000899866","role":"Officer (EVP, Chief Financial Officer)","n_filings":2,"first_seen":"2018-02-08","last_seen":"2018-07-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000875045","name":"BIOGEN INC.","url":"/issuer/0000875045","role":"Officer (Executive VP and CFO)","n_filings":14,"first_seen":"2008-02-14","last_seen":"2017-04-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001409601","retrieved_at":"2026-08-22T20:05:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}